Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 USD | +0.61% | +0.80% | +42.30% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
May. 03 | AIB buys back EUR999 million worth of shares from Irish government | AN |
Sales 2024 * | 4.56B 4.96B | Sales 2025 * | 4.34B 4.73B | Capitalization | 12.64B 13.76B |
---|---|---|---|---|---|
Net income 2024 * | 1.76B 1.92B | Net income 2025 * | 1.56B 1.7B | EV / Sales 2024 * | 2.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.91 x |
P/E ratio 2024 * |
7.28
x | P/E ratio 2025 * |
7.57
x | Employees | 10,551 |
Yield 2024 * |
5.76% | Yield 2025 * |
6.1% | Free-Float | 68.01% |
Latest transcript on AIB Group plc
1 day | +0.61% | ||
1 week | +0.80% | ||
1 month | +5.28% | ||
3 months | +23.45% | ||
6 months | +30.69% | ||
Current year | +42.30% |
Managers | Title | Age | Since |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 15-12-31 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 13-08-31 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 21-01-21 |
James Pettigrew
CHM | Chairman | 65 | 21-10-27 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 16-10-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 11.37 | +0.61% | 1,097 |
24-05-30 | 11.3 | -1.13% | 882 |
Delayed Quote OTC Markets, May 31, 2024 at 03:04 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.25% | 582B | |
+17.18% | 313B | |
+17.02% | 251B | |
+19.36% | 209B | |
+20.86% | 180B | |
+25.17% | 169B | |
+9.10% | 164B | |
+9.79% | 154B | |
-8.02% | 140B |
- Stock Market
- Equities
- A5G Stock
- AIBGY Stock